Daniel Curran, M.D. is a Chief Executive Officer at Timberlyne Therapeutics based in Wellesley Hills, Massachusetts, United States, North America. Senior pharmaceutical physician executive who has broad therapeutic area expertise and a unique background of experience in corporate strategy, business development, drug discovery and development activities from preclinical stage through product registration. Successfully developed and registered numerous new medicines globally including LIVTENCITY and ADZYNMA and expanded the label for innovative medicines TAKHZYRO and VONVENDI.
Current Position: Chief Executive Officer
Company: Timberlyne Therapeutics
Location: Wellesley Hills, Massachusetts, United States, North America
Social: Professional profiles available
Network: Extensive professional connections